Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
MaxCyte ( (MXCT) ) has provided an update.
MaxCyte, Inc., a company in the biotechnology industry, has announced a change in the major holdings of its shares. The notification indicates that BlackRock, Inc. has acquired and now holds a total of 8.44% of MaxCyte’s voting rights, marking a slight decrease from the previous 8.52%. This adjustment reflects a minor shift in voting influence, potentially impacting strategic decisions and shareholder dynamics within the company.
More about MaxCyte
YTD Price Performance: -10.64%
Average Trading Volume: 44,487
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £345.1M
For detailed information about MXCT stock, go to TipRanks’ Stock Analysis page.
